期刊文献+

非苯二氮类催眠药作用靶位的特异性与评价 被引量:5

Specificity of Effect Target Site and Evaluation of Non-Benzodiazepine Sedative Hypnotic Drugs
暂未订购
导出
摘要 目的:评价非苯二氮类催眠药作用研究和临床应用,反映催眠药进展的侧面。方法:查阅近期国内、外有关文献,进行分析。结果与结论:非苯二氮类催眠药的进展迅速,有别于传统的催眠药,对受体亚型的选择性强、血浆半衰期短、不良反应小,缩短睡眠的潜伏期,改善睡眠维持和提高睡眠质量,增加睡眠总时间,标志一个新的里程的开始。成为开启解脱失眠痛苦的治疗之门的一把金“药匙”。 OBJECTIVE:To summarize the aspect of the research work and clinical application of non - benzodiazepine sedative hypnotic drugs, and reflect the progress of this kind of drugs. METHODS:To collecte medical literatures in recent years at home and abroad. RESULTS & CONCLUTION:Advance in non - benzodiazepine sedative hypnotic drugs has been swift in recent years, this kind of drugs have higher selectivity to subtype of receptor, short plasma half- life and less adverse reactions. They can shorten latency phase of the sleep, improve and maintai sleep quality as well as increasing cumulative time of the sleep. This indicates the beginning of a new coupe of development,it will become a gold "drug key"to the door of treatment of the patients with insomnia.
作者 张石革
出处 《中国医院用药评价与分析》 2006年第2期72-75,共4页 Evaluation and Analysis of Drug-use in Hospitals of China
关键词 失眠 非苯二氮[艹卓]类催眠药 睡眠改善 评价 insomnia non- benzodiazepine sedative hypnotic drugs sleep improvement evaluation
  • 相关文献

参考文献16

  • 1Melton ST,Wood JM,KirkwoodCK.Eszopiclone for insomnia[J].Ann Pharmacotherapy,2005,39(10):1 659.
  • 2McCall WV.Diagnosis and management of insomnia in older people[J].J Am GeriatrSoc,2005,53(7 Suppl):S272.
  • 3Davies M,Glen NJ,Derry JMC,et al.Characterization of the interaction of zopiclone withgamma-aminobutyric acid type a receptor[J].Mol Pharmacol,2000,58(4):756.
  • 4Mikkelsen JD,Soderman A,Kiss A,et al.Effects of benzodiazepines receptor agonists onthe hypothalamicpituitary-adrenocortical axis[J].Eur J Pharmacol,2005,519(3):223.
  • 5Walsh JK.Pharmacologic management of isomnia[J].J Clin Psychiatry,2004,65 (Suppl16):41.
  • 6Yasui M,Kato A,Kanemasa T,et al.Pharmacological profiles of benzodiazepinergichypnotics and correlations with receptor subtypes[J].Nihon Shinkei Seishin YakurigakuZasshi,2005,25(3):143.
  • 7Glass J,Lanctot KL,Herrmann N,et al.Sedative hypnotics in older people withinsomnia:meta-analysis of risks and benefits[J].BMJ,2005,331(7 526):1 169.
  • 8Krystal AD,Walsh JK,Laska E,et al.Sustained efficacy of eszopiclone over 6 months ofnightly treatment results of a randomized double-blind,placebo-controlled study in adultswiyh chronic insomnia[J].Sleep,2003,26 (7):793.
  • 9Rosenberg R,Caron J,Roth T,et al.An assessment of the efficacy and safety ofeszopiclone in the treatment of transient insomnia in healthy adults[J].SleepMed,2005,6(1):15.
  • 10Zammit GK,Mcnabb LJ,Caron J,et al.Efficacy and safety of aszopiclone across 6-week oftreatment for primary insomnia[J].Curr Med Res Opin,2004,20(12):1 979.

同被引文献30

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部